|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Marley AR and Nan H: Epidemiology of
colorectal cancer. Int J Mol Epidemiol Genet. 7:105–114.
2016.PubMed/NCBI
|
|
3
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang Y, Chen Z and Li J: The current
status of treatment for colorectal cancer in China: A systematic
review. Medicine (Baltimore). 96:e82422017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Favoriti P, Carbone G, Greco M, Pirozzi F,
Pirozzi RE and Corcione F: Worldwide burden of colorectal cancer: A
review. Updates Surg. 68:7–11. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fakih MG: Metastatic colorectal cancer:
Current state and future directions. J Clin Oncol. 33:1809–1824.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Taborda MI, Ramirez S and Bernal G:
Circular RNAs in colorectal cancer: Possible roles in regulation of
cancer cells. World J Gastrointest Oncol. 9:62–69. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Salzman J: Circular RNA expression: Its
potential regulation and function. Trends Genet. 32:309–316. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Meng X, Li X, Zhang P, Wang J, Zhou Y and
Chen M: Circular RNA: An emerging key player in RNA world. Brief
Bioinform. 18:547–557. 2017.PubMed/NCBI
|
|
10
|
Memczak S, Jens M, Elefsinioti A, Torti F,
Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer
M, et al: Circular RNAs are a large class of animal RNAs with
regulatory potency. Nature. 495:333–338. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hansen TB, Jensen TI, Clausen BH, Bramsen
JB, Finsen B, Damgaard CK and Kjems J: Natural RNA circles function
as efficient microRNA sponges. Nature. 495:384–388. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang P and He X: Current research on
circular RNAs associated with colorectal cancer. Scand J
Gastroenterol. 52:1203–1210. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang P, Zuo Z, Shang W, Wu A, Bi R, Wu J,
Li S, Sun X and Jiang L: Identification of differentially expressed
circular RNAs in human colorectal cancer. Tumor Biol. Mar
28–2017.(Epub ahead of print).
|
|
14
|
Kristensen LS, Hansen TB, Venø MT and
Kjems J: Circular RNAs in cancer: Opportunities and challenges in
the field. Oncogene. 37:555–565. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jiang W, Zhang X, Chu Q, Lu S, Zhou L, Lu
X, Liu C, Mao L, Ye C, Timko MP, et al: The circular RNA profiles
of colorectal tumor metastatic cells. Front Genet. 9:342018.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xu XW, Zheng BA, Hu ZM, Qian ZY, Huang CJ,
Liu XQ and Wu WD: Circular RNA hsa_circ_000984 promotes colon
cancer growth and metastasis by sponging miR-106b. Oncotarget.
8:91674–91683. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bachmayr-Heyda A, Reiner AT, Auer K,
Sukhbaatar N, Aust S, Bachleitner-Hofmann T, Mesteri I, Grunt TW,
Zeillinger R and Pils D: Correlation of circular RNA abundance with
proliferation-exemplified with colorectal and ovarian cancer,
idiopathic lung fibrosis, and normal human tissues. Sci Rep.
5:80572015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Maity A and Das B: N6-methyladenosine
modification in mRNA: Machinery, function and implications for
health and diseases. FEBS J. 283:1607–1630. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Deng X, Su R, Weng H, Huang H, Li Z and
Chen J: RNA N6-methyladenosine modification in cancers: Current
status and perspectives. Cell Res. 28:507–517. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lin S, Choe J, Du P, Triboulet R and
Gregory RI: The m(6)A methyltransferase METTL3 promotes translation
in human cancer cells. Mol Cell. 62:335–345. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen M, Wei L, Law CT, Tsang FH, Shen J,
Cheng CL, Tsang LH, Ho DW, Chiu DK, Lee JM, et al: RNA
N6-methyladenosine methyltransferase-like 3 promotes liver cancer
progression through YTHDF2-dependent posttranscriptional silencing
of SOCS2. Hepatology. 67:2254–2270. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cai X, Wang X, Cao C, Gao Y, Zhang S, Yang
Z, Liu Y, Zhang X, Zhang W and Ye L: HBXIP-elevated
methyltransferase METTL3 promotes the progression of breast cancer
via inhibiting tumor suppressor let-7g. Cancer Letters. 415:11–19.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Taketo K, Konno M, Asai A, Koseki J,
Toratani M, Satoh T, Doki Y, Mori M, Ishii H and Ogawa K: The
epitranscriptome m6A writer METTL3 promotes chemo- and
radioresistance in pancreatic cancer cells. Int J Oncol.
52:621–629. 2018.PubMed/NCBI
|
|
24
|
Brattain MG, Fine WD, Khaled FM, Thompson
J and Brattain DE: Heterogeneity of malignant cells from a human
colonic carcinoma. Cancer Res. 41:1751–1756. 1981.PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shao T, Pan YH and Xiong XD: Circular RNA:
An important player with multiple facets to regulate its parental
gene expression. Mol Ther Nucleic Acids. 23:369–376. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Huang X, Zhang W and Shao Z: Prognostic
and diagnostic significance of circRNAs expression in lung cancer.
J Cell Physiol. 234:18459–18465. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ma Y, Zheng L, Gao Y, Zhang W, Zhang Q and
Xu Y: A comprehensive overview of circRNAs: Emerging biomarkers and
potential therapeutics in gynecological cancers. Front Cell Dev
Biol. 9:7095122021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tian J, Xi X, Yu J, Huang Q, Ma R, Zhang
X, Li H and Wang L: CircRNA hsa_circ_0004585 as a potential
biomarker for colorectal cancer. Cancer Manag Res. 11:5413–5423.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li RD, Guan M, Zhou Z, Dong SX and Liu Q:
The role of circRNAs in the diagnosis of colorectal cancer: A
meta-analysis. Front Med (Lausanne). 8:7662082021. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Huang G, Zhu H, Shi Y, Wu W, Cai H and
Chen X: cir-ITCH plays an inhibitory role in colorectal cancer by
regulating the Wnt/β-catenin pathway. PLoS One. 10:e01312252015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhu M, Xu Y, Chen Y and Yan F: Circular
BANP, an upregulated circular RNA that modulates cell proliferation
in colorectal cancer. Biomed Pharmacother. 88:138–144. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Peng K, Jiang P, Du Y, Zeng D, Zhao J, Li
M, Xia C, Xie Z and Wu J: Oxidized low-density lipoprotein
accelerates the injury of endothelial cells via
circ-USP36/miR-98-5p/VCAM1 axis. IUBMB Life. 73:177–187. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wu D, Jia H, Zhang Z and Li S: Circ-PRMT5
promotes breast cancer by the miR-509-3p/TCF7L2 axis activating the
PI3K/AKT pathway. J Gene Med. 23:e33002021. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jin Y, Yu LL, Zhang B, Liu CF and Chen Y:
Circular RNA hsa_circ_0000523 regulates the proliferation and
apoptosis of colorectal cancer cells as miRNA sponge. Braz J Med
Biol Res. 51:e78112018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zheng Q, Bao C, Guo W, Li S, Chen J, Chen
B, Luo Y, Lyu D, Li Y, Shi G, et al: Circular RNA profiling reveals
an abundant circHIPK3 that regulates cell growth by sponging
multiple miRNAs. Nat Commun. 7:112152016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu K, Yao H, Lei S, Xiong L, Qi H, Qian
K, Liu J, Wang P and Zhao H: The miR-124-p63 feedback loop
modulates colorectal cancer growth. Oncotarget. 8:29101–29115.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Barh D, Malhotra R, Ravi B and Sindhurani
P: MicroRNA let-7: An emerging next-generation cancer therapeutic.
Curr Oncol. 17:70–80. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Johnson CD, Esquela-Kerscher A, Stefani G,
Byrom M, Kelnar K, Ovcharenko D, Wilson M, Wang X, Shelton J,
Shingara J, et al: The let-7 microRNA represses cell proliferation
pathways in human cells. Cancer Res. 67:7713–7722. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kumar MS, Erkeland SJ, Pester RE, Chen CY,
Ebert MS, Sharp PA and Jacks T: Suppression of non-small cell lung
tumor development by the let-7 microRNA family. Proc Natl Acad Sci
USA. 105:3903–3908. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Vu LP, Pickering BF, Cheng Y, Zaccara S,
Nguyen D, Minuesa G, Chou T, Chow A, Saletore Y, MacKay M, et al:
The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid
differentiation of normal hematopoietic and leukemia cells. Nat
Med. 23:13692017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Choe J, Lin S, Zhang W, Liu Q, Wang L,
Ramirez-Moya J, Du P, Kim W, Tang S, Sliz P, et al: mRNA
circularization by METTL3-eIF3h enhances translation and promotes
oncogenesis. Nature. 561:556–560. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li X, Tang J, Huang W, Wang F, Li P, Qin
C, Qin Z, Zou Q, Wei J, Hua L, et al: The M6A methyltransferase
METTL3: Acting as a tumor suppressor in renal cell carcinoma.
Oncotarget. 8:96103–96116. 2017. View Article : Google Scholar : PubMed/NCBI
|
